Mikael Dolsten joins Israel biotech company

Immunai, a leading artificial intelligence (AI) biotech company specializing in immune system mapping, has appointed Mikael Dolsten, M.D., Ph.D., to its Board of Directors. Dolsten, who served as Pfizer’s chief scientific officer and…